Background and activities

Dr. Siver A. Moestue earned his PhD at the Norwegian University of Science and Technology (NTNU). He is currently a postdoctoral research fellow at the MR Centre, NTNU, on a personal research grant from the Norwegian Cancer Society.  Trained a MSc. Pharm at the University of Oslo, he started his career as a preclinical researcher in GE Healthcare. Here, he was involved in development of molecularly targeted contrast agents for SPECT/PET, and development of the Sonazoid® microbubble.  In his current research, Dr. Moestue is investigating the use of MRI and MRS in cancer therapy monitoring, with special focus on metabolic biomarkers.

Scientific, academic and artistic work

Displaying a selection of activities. See all publications in the database

Journal publications